March 6, 2026

The collaboration work with the Department of Urology at the Graduate School of Medicine, Kyoto University, have been accepted for publication in *Molecular Cancer Therapeutics*. Project Leader Sasanuma and Researcher Kano participated in the study.
The paper demonstrates that a combination of PARP and ATR inhibitors is a promising new treatment strategy for prostate cancer patients with CDK12 abnormalities. Congratulations!

10th January, 2025

Happy to hear good news! The collaboration work with Junko Murai in Ehime Univ. has been accepted in Molecular Cell. Congratulations!